부산대학교 도서관

McFaline-Figueroa, José L.; Srivatsan, Sanjay; Hill, Andrew J.; Gasperini, Molly; Jackson, Dana L.; Saunders, Lauren; Domcke, Silvia; Regalado, Samuel G.; Lazarchuck, Paul; Alvarez, Sarai; Monnat, Raymond J., Jr.; Shendure, Jay; Trapnell, Cole

In Cell Genomics 14 February 2024 4(2)

Giglio RM; Department of Molecular Pharmacology and Therapeutics, Columbia University Medical Center, New York, NY 10032, USA.; Hou N; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Wyatt A; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Hong J; Department of Computer Science, Columbia University, New York, NY 10027, USA.; Shi L; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Vaikunthan M; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Fuchs H; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Nima JP; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Malinowski SW; Department of Oncologic Pathology, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Ligon KL; Department of Oncologic Pathology, Brigham and Women's Hospital, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; McFaline-Figueroa JR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Yosef N; Department of Electrical Engineering and Computer Sciences, University of California, Berkeley, Berkeley, CA 94720, USA.; Center for Computational Biology, University of California, Berkeley, Berkeley, CA 94720, USA.; Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel.; Azizi E; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Department of Computer Science, Columbia University, New York, NY 10027, USA.; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.; Data Science Institute, Columbia University, New York, NY 10027, USA.; McFaline-Figueroa JL; Department of Biomedical Engineering, Columbia University, New York, NY 10027, USA.; Irving Institute for Cancer Dynamics, Columbia University, New York, NY 10027, USA.; Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Budhu JA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Neurology, Weill Cornell Medicine, Joan & Sanford I. Weill Medical College of Cornell University, New York, New York, USA.; Chukwueke UN; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Jackson S; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Lee EQ; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; McFaline-Figueroa JR; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Willmarth N; American Brain Tumor Association, Chicago, Illinois, USA.; Dalmage M; Division of Biological Sciences, University of Chicago Pritzker School of Medicine, Chicago, Illinois, USA.; Kawachi I; Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.; Arons D; National Brain Tumor Society, Newton, Massachusetts, USA.; Chang SM; Division of Neuro-Oncology, University of California San Francisco and Weill Institute for Neurosciences, San Francisco, California, USA.; Galanis E; Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.; Hervey-Jumper SL; Department of Neurological Surgery, University of California San Francisco and Weill Institute for Neurosciences, San Francisco, California, USA.; Wen PY; Division of Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.; Division of Neuro-Oncology, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Porter AB; Department of Neurology, Mayo Clinic Cancer Center, Phoenix, Arizona, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Lim-Fat MJ; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.; Iorgulescu JB; Molecular Diagnostics Laboratory, Department of Hematopathology, Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Rahman R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Bhave V; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Muzikansky A; Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts.; Woodward E; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Whorral S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Allen M; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Touat M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Neurologie 2-Mazarin, Paris, France.; Li X; Shandong University, Jinan, China.; Xy G; Shandong University, Jinan, China.; Patel J; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.; Gerstner ER; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.; Kalpathy-Cramer J; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts.; Youssef G; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; McFaline-Figueroa JR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Beroukhim R; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Huang RY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Ligon KL; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9509333 Publication Model: Print Cited Medium: Internet ISSN: 1538-6899 (Electronic) Linking ISSN: 10802371 NLM ISO Abbreviation: Continuum (Minneap Minn) Subsets: MEDLINE

Rahman R; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Trippa L; Dana-Farber Cancer Institute, Boston, MA.; Lee EQ; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Arrillaga-Romany I; Massachusetts General Hospital, Boston, MA.; Fell G; Dana-Farber Cancer Institute, Boston, MA.; Touat M; Brigham and Women's Hospital, Boston, MA.; Sorbonne Universite, Hôpitaux Universitaires La Pitié Salpêtrière, Paris, France.; McCluskey C; Dana-Farber Cancer Institute, Boston, MA.; Wiley J; Dana-Farber Cancer Institute, Boston, MA.; Gaffey S; Dana-Farber Cancer Institute, Boston, MA.; Drappatz J; University of Pittsburgh, Pittsburgh, PA.; Welch MR; Division of Neuro-Oncology, Department of Neurology and Herbert Irving Comprehensive Cancer Center, Columbia University Vagelos College of Physicians and Surgeons, NewYork-Presbyterian, New York, NY.; Galanis E; Mayo Clinic, Rochester, MN.; Ahluwalia MS; Miami Cancer Institute, Miami, FL.; Colman H; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.; Nabors LB; University of Alabama at Birmingham, Birmingham, AL.; Hepel J; Rhode Island Hospital, Providence, RI.; Elinzano H; Rhode Island Hospital, Providence, RI.; Schiff D; University of Virginia, Charlottesville, VA.; Chukwueke UN; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Beroukhim R; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Nayak L; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; McFaline-Figueroa JR; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Batchelor TT; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Rinne ML; Dana-Farber Cancer Institute, Boston, MA.; Kaley TJ; Memorial Sloan Kettering Cancer Center, New York, NY.; Lu-Emerson C; Maine Medical Center, Portland, ME.; Mellinghoff IK; Memorial Sloan Kettering Cancer Center, New York, NY.; Bi WL; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Arnaout O; Brigham and Women's Hospital, Boston, MA.; Peruzzi PP; Brigham and Women's Hospital, Boston, MA.; Haas-Kogan D; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Tanguturi S; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Cagney D; Mater Private, Dublin, Ireland.; Aizer A; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Doherty L; Dana-Farber Cancer Institute, Boston, MA.; Lavallee M; Dana-Farber Cancer Institute, Boston, MA.; Fisher-Longden B; Dana-Farber Cancer Institute, Boston, MA.; Dowling S; Dana-Farber Cancer Institute, Boston, MA.; Geduldig J; Dana-Farber Cancer Institute, Boston, MA.; Watkinson F; Dana-Farber Cancer Institute, Boston, MA.; Pisano W; Dana-Farber Cancer Institute, Boston, MA.; Malinowski S; Dana-Farber Cancer Institute, Boston, MA.; Ramkissoon S; Dana-Farber Cancer Institute, Boston, MA.; Santagata S; Brigham and Women's Hospital, Boston, MA.; Meredith DM; Brigham and Women's Hospital, Boston, MA.; Chiocca EA; Brigham and Women's Hospital, Boston, MA.; Reardon DA; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Alexander BM; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Ligon KL; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.; Wen PY; Dana-Farber Cancer Institute, Boston, MA.; Brigham and Women's Hospital, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Heo J; Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.; Schifino AG; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.; Department of Kinesiology, University of Georgia, Athens, GA, USA.; McFaline-Figueroa J; Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.; Miller DL; Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.; Hoffman JR; Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.; Noble EE; Department of Nutritional Science, University of Georgia, Athens, GA, USA.; Greising SM; School of Kinesiology, University of Minnesota, Minneapolis, MN, USA.; Call JA; Department of Physiology and Pharmacology, University of Georgia, Athens, GA, USA.; Regenerative Bioscience Center, University of Georgia, Athens, GA, USA.

Publisher: John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders Country of Publication: Germany NLM ID: 101552883 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-6009 (Electronic) Linking ISSN: 21905991 NLM ISO Abbreviation: J Cachexia Sarcopenia Muscle Subsets: MEDLINE

Christ SM; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland.; Youssef G; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Tanguturi SK; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.; Cagney D; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.; Shi D; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.; McFaline-Figueroa JR; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Chukwueke U; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hertler C; Competence Center Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland.; Andratschke N; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland.; Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Haas-Kogan D; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.; Guckenberger M; Department of Radiation Oncology, University Hospital and University of Zurich, Zurich, Switzerland.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Rahman R; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA.

Publisher: Elsevier Ireland Ltd. on behalf of European Society for Radiotherapy and Oncology Country of Publication: Ireland NLM ID: 101713416 Publication Model: eCollection Cited Medium: Internet ISSN: 2405-6308 (Electronic) Linking ISSN: 24056308 NLM ISO Abbreviation: Clin Transl Radiat Oncol Subsets: PubMed not MEDLINE

Deng D; Massachusetts Institute of Technology, Harvard University, Boston, Massachusetts, USA.; Hammoudeh L; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Department of Radiation Medicine, Oregon Health and Science University, Portland, Oregon, USA.; Youssef G; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Chen YH; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts¸USA.; Shin KY; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Lim-Fat MJ; Division of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; McFaline-Figueroa JR; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Chukwueke UN; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Tanguturi S; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Reardon DA; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Lee EQ; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Nayak L; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Bi WL; Department of Neurosurgery, Brigham and Women's Hospital, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Arnaout O; Department of Neurosurgery, Brigham and Women's Hospital, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Ligon KL; Department of Pathology, Brigham and Women's Hospital, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.; Wen PY; Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts¸ USA.; Rahman R; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

McFaline-Figueroa JL; Department of Biomedical Engineering, Columbia University, New York, NY, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Srivatsan S; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Medical Scientist Training Program, University of Washington, Seattle, WA, USA.; Hill AJ; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Gasperini M; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Jackson DL; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Saunders L; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Domcke S; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Regalado SG; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Lazarchuck P; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Alvarez S; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Monnat RJ Jr; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.; Shendure J; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.; Allen Discovery Center for Cell Lineage Tracing, Seattle, WA, USA.; Howard Hughes Medical Institute, University of Washington, Seattle, WA, USA.; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.; Trapnell C; Department of Genome Sciences, University of Washington, Seattle, WA, USA..; Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA.; Allen Discovery Center for Cell Lineage Tracing, Seattle, WA, USA.; Brotman Baty Institute for Precision Medicine, Seattle, WA, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE